Beruflich Dokumente
Kultur Dokumente
General Considerations
General Considerations
General Considerations
General Considerations
Etiology
Genetic factor
Inborn
Acquired
Causative factor
Classification
Classified by etiology
Symptomatic (secondary)
epilepsy
Cryptogenic epilepsy
Classification
Classified by epileptic
seizures
Classification
Classification
Generalized seizures
Absence seizures
Typical absence
Atypical absence
Myoclonic seizures
Clonic seizures
Tonic seizures
Tonic-clonic seizures
Atonic seizures
Infant spasm, tonic-spasm
Classification
Clinical manifestation
Partial epilepsy
Clinical manifestation
Partial epilepsy
Clinical manifestation
Generalized seizures
Clinical manifestation
Generalized seizures
Diagnosis of epilepsy
Epilepsy--grand malsecondary
(symptomatic) mental retardation
Epilepsycentrotemporal spike wave-benign childhood epilepsy
Diagnosis of epilepsy
Clinical picture
Clinical history
Description of Sz
Symptomatology
Physical/Neurologic
examination
Therapy
EEG
Background activity
Epileptiform activity
Interictal
Ictal
Postictal
Laboratory tests
Neuroimaging
Differenial diagnosis
Febrile Seizures
Migraine
Differenial diagnosis
Breath-holding spells
Sleeping disturbance
Sleepwalking ,
Nightmare
Night terrors
Differenial diagnosis
Masturbation
Pseudoseizures
Tourette sydrome
An approach to Seizures
Is it a s e iz u r e ?
Yes
No
I s i t s y m p t o m a t ic o f a n a c u t e i lln e s s
No
W h a t is t h e p r o b a b l e c a u s e ?
n a t u r a l h is t o r y
in v e s t ig a t io n
tre a tm e n t
Yes
D ia g n o s e a n d T r e a t
Treatment of epilepsy
Early treatment
Treatment as the types of epileptic seizure
Treatment with one drug
Individual therapy
Long course of treatment
Slow drug withdrawal
Periodic re-examination
Treatment of epilepsy
AEDs selection on types of epileptic seizure
types
drugs
Tonic-clonic seizures
Absence seizures
Myoclonic seizures
Partial seizures
Infantile spasms
Antiepilepsy drugs,AEDs
drug
Dosage
mg/kg
Effective blood
level ug/ml
T1/2
Side effect
VPA
15-50
50-120
8h
Ganstric discomfort,
sthenic
apptite , hepatic dysfunction
CBZ
15-30
4-12
15h
PHT
4-8
10-20
22h
PB
4-6
20-40
4d
ESX
20
40-120
55h
CZP
0.01-0.2
20-80
55h
ACTH
25-40u
Gastrointestinal
disorder,
headache , WBC decrease,
Drowsiness, Skin rash, unsteady
gait, ataxia, salivate
Hyperfuction of the adrenal
cortex
Dosage
mg/kg
TMP
3-10
LTG
5-15 (used
with VPA
1-5)
GBP
20-50
Effective blood
level ug/ml
T1/2
Side effect
1.1-3.0
20-30h
infant
15h
20-30h
2-3
5-7
Treatment of epilepsy
1
30%
70%
2
25%
5%
3
20%
10%
10%
VNS
7%
3%
5%
10%
3%
3%
7%
Status epilepticus
Thank you